Real-World Evidence: Multicenter Efficacy and Toxicity Analysis of Nintedanib With Docetaxel as Second-Line Treatment in Mexican Patients With Advanced Lung Adenocarcinoma oleh Jeronimo Rafael Rodríguez-Cid, Saul Campos-Gomez, Vanessa García-Montes, Manuel Magallanes-Maciel, Rodrigo Rafael Flores-Mariñelarena, Valeria Michelle Fernández-Garibay, Iván Romarico González-Espinoza, Juan Paulo Ceja-García, Juan Carlos Cázarez-Price, Luis Martínez-Barrera, Leopoldo Barriguete-Parra, Carlos Jose Zuloaga-Fernandez, Roberto Kuri-Exsome, David Suárez-García, Jorge Ignacio Gonzalez-Villanueva, Noé Flores-Anaya, Jose Antonio Acevedo-Delgado, Alma Magdalena Astorga-Ramos, Raquel Gerson-Cwilich, Alberto Villalobos-Prieto, Claudia Rodríguez-Silva, Maria Fernanda Noriega-Iriondo, Leticia Vázquez-Cortés, Eusebio Perales-Rodríguez, Alicia Acosta-Espinoza, Yareni Perez-Lozano, Daniel Capdeville-García, Jorge Arturo Alatorre-Alexander